Matters of the Heart copertina

Matters of the Heart

Matters of the Heart

Di: Dr. Rahul Muthalaly
Ascolta gratuitamente

3 mesi a soli 0,99 €/mese

Dopo 3 mesi, 9,99 €/mese. Si applicano termini e condizioni.

A proposito di questo titolo

 Matters of the Heart was created to fill the void of conversational yet educational and rigorously scientific medical content. I'm your host, Dr. Rahul Muthalaly, an academic cardiologist in Melbourne, Australia. I interview masters in the cardiology field to explore the cutting edge of cardiovascular medicine. I hope that we can gather the tools, tactics and techniques to sharpen our clinical and research practice.Copyright 2026 Matters of the Heart Disturbo fisico e malattia Igiene e vita sana Scienza Scienze biologiche
Episodi
  • ESC Review - ALONE-AF and ODYSSEY-HCM

    ESC Review - ALONE-AF and ODYSSEY-HCM
    Sep 4 2025

    ¡Hola listeners!

    Rahul has returned from the ESC meeting in Madrid full of beans and ready to burst about two interesting trials. Listen in for a short brief on the ALONE-AF trial examining anticoagulation withdrawal after AF ablation and the use of myosin inhibitors in HCM patients without obstruction.

    If you like the show, please leave a review - we would love to hear from you.

    Mostra di più Mostra meno
    13 min
  • The Arrhythmic Mitral Valve

    The Arrhythmic Mitral Valve
    Aug 28 2025

    Have you ever had a confused look on your face while someone waxes lyrical about the arrhythmic mitral valve complex? It's not the latest in the DSM-V. Join Rahul for a solo return episode where we run through what constitutes an arrhythmic mitral valve and what you can do about it.

    Mostra di più Mostra meno
    19 min
  • Hypertrophic Cardiomyopathy with Dr. Andris Ellims

    Hypertrophic Cardiomyopathy with Dr. Andris Ellims
    May 6 2024

    Thicken your knowledge about hypertrophic cardiomyopathy with Rahul as he interviews the superb Dr. Andris Ellims, head of the Alfred HCM clinic. This episode includes a brief update of HCM diagnosis and genetics before exploring contemporary management strategies for HCM.

    As you might be aware, mavacamten (a cardiac myosin inhibitor) has just been approved in Australia for the treatment of obstructive HCM. Now is a great time to get familiar with the data behind the drug and get some practical tips from one of Australia's best on how to use it in your practice.

    Mostra di più Mostra meno
    1 ora e 15 min
Ancora nessuna recensione